The structural landscape of the contemporary pharmaceutical supply chain has entered an era of unprecedented consolidation and rapid transformation. Driven by intense margin compression, shifting vertical integration metrics, and the rapid expansion of digital health platforms, corporate actors across the healthcare sector are increasingly deploying mergers and acquisitions (M&A) as primary corporate growth engines to […]